Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].

Zhonghua bing li xue za zhi = Chinese journal of pathology - 1 Dec 2011

Yang Xi, Dong Ying, Zhang Xiao-ming, Liang Ying, Zhang Ying, Meng Yi-ting, Wang Ying, Wang Wei, Nong Lin, Li Ting, Liao Qin-Ping

Abstract excerpt

OBJECTIVE: To investigate the clinicopathologic and prognostic implications of phosphoinositide 3 kinase (PI3K)/AKT pathway alterations in endometrial cancers of Chinese women. METHODS: The expression of PTEN, p-AKT, and ER/PR was assessed in 71 cases of endometrial carcinoma by immunohistochemis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Hysterectomy

Share to Proto-Oncogene Proteins c-akt

Share to PTEN Phosphohydrolase

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 22336203

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-22336203-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].PMID 22336203Read ↗

Activation of PI3K/Akt/mTOR pathway and dual inhibitors of PI3K and mTOR in endometrial cancer.Semantic proximity Read ↗

[Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].Semantic proximity Read ↗

Concomitant activation of AKT with extracellular-regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosiss.Semantic proximity Read ↗

[Study of the mutation and expression of PTEN gene in endometrial carcinoma and epithelial ovarian cancer].Semantic proximity Read ↗

[PTEN expression in endometrial cancer and the prognosis].Semantic proximity Read ↗

Somatic mutations are present in all members of the AKT family in endometrial carcinomaSemantic proximity Read ↗

Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.Semantic proximity Read ↗

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.Semantic proximity Read ↗

Molecular alterations of PI3K/Akt/mTOR pathway: a therapeutic target in endometrial cancer.Semantic proximity Read ↗

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomasSemantic proximity Read ↗

Role of exon 7 PTEN Gene in Endometrial Carcinoma.Semantic proximity Read ↗

Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.